中文版
ChemBest-Your Best Partner-Reliable And Trustworthy!
Home > Products SHARE THIS:
MCC950 Sodium
Product Number :
CL1969
Product Name :
MCC950 Sodium
CAS No. :
256373-96-3
Synonyms :
CP-456773 Sodium
Chemical Name :
Molecular Formula :
C20H23N2NaO5S
Molecular Weight :
426.46
Molecular Structure :
Appearance :
Off-white to yellow powder
Specification :
98+%
Application :
Registration :
Storage Condition :

MCC950 is an inhibitor of NOD-like receptor protein 3 (NLRP3) inflammasome activation. It inhibits ATP-induced IL-1β release in LPS-primed mouse bone marrow-derived macrophages (BMDMs; IC50 = 7.5 nM), as well as cytosolic LPS-induced IL-1β release in Pam3CSK4-primed mouse BMDMs at 0.1 and 1 µM, indicating inhibition of both canonical and non-canonical NLRP3 inflammasome activation, respectively. MCC950 is selective for NLRP3 over NLRC4 and absent in melanoma 2 (AIM2) inflammasomes and does not inhibit LPS-induced NLRP3 priming in mouse BMDMs at 10 µM. It reduces ox-LDL-induced increases in caspase-1 activity and inhibits pyroptosis in THP-1 macrophages when used at a concentration of 1 µM. MCC950 (10 mg/kg) reduces myocardial fibrosis in mice following myocardial infarction induced by left coronary artery ligation. It improves forelimb grip strength and reduces spinal edema in a mouse model of spinal crush injury at the same dose.

Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.

  • MCC950 is an inhibitor of NOD-like receptor protein 3 (NLRP3) inflammasome activation. It inhibits ATP-induced IL-1β release in LPS-primed mouse bone marrow-derived macrophages (BMDMs; IC50 = 7.5 nM), as well as cytosolic LPS-induced IL-1β release in Pam3CSK4-primed mouse BMDMs at 0.1 and 1 µM, indicating inhibition of both canonical and non-canonical NLRP3 inflammasome activation, respectively. MCC950 is selective for NLRP3 over NLRC4 and absent in melanoma 2 (AIM2) inflammasomes and does not inhibit LPS-induced NLRP3 priming in mouse BMDMs at 10 µM. It reduces ox-LDL-induced increases in caspase-1 activity and inhibits pyroptosis in THP-1 macrophages when used at a concentration of 1 µM. MCC950 (10 mg/kg) reduces myocardial fibrosis in mice following myocardial infarction induced by left coronary artery ligation. It improves forelimb grip strength and reduces spinal edema in a mouse model of spinal crush injury at the same dose.
  • Capsiate

    Ansamitocin P-3

    Verteporfin

    Brefeldin A

    ICG-001

    Temoporfin

    Y-27632 Dihydrochloride

    Resatorvid (TAK-242)

    Cobimetinib (GDC-0973)

    GSK-690693

    GSK2193874

    AICAR (Acadesine)

Request A Quote
Your Name(required)
Email(required)
Product Name(required)
Country or Region(required)
Organization Name(required)
Messages(required)
Captcha(required)
Sending...

Products

By Alphabetical Product Index:
By CAS No.: